WuXi AppTec Joins the Pharmaceutical Supply Chain Initiative to Strengthen Responsible Practices and Supply Chain Resilience Pharmaceutical Supply WuXi AppTec, a global leader providing comprehensive research, development, and manufacturing services to the pharmaceutical and life sciences industries, has announced its…
Ailux Biologics UCB\u2019s Strategic Collaboration with Ailux Biologics Ailux Biologics UCB, a leading global biopharmaceutical company, and XtalPi, an industry pioneer in AI-powered drug discovery, have announced a landmark license agreement involving XtalFold™, an advanced biologics AI platform. Developed by…
Novo Nordisk and Valo Health Expand Partnership to Accelerate Cardiometabolic Disease Treatment Discovery Novo Nordisk A/S and Valo Health have announced a significant expansion of their collaboration aimed at discovering and developing innovative treatments for cardiometabolic diseases, including obesity, type…
Impact of High-Dose Glucocorticoid Therapy on Long-Term Health Neurocrine Biosciences has announced the publication of a comprehensive narrative review exploring the complexities of traditional glucocorticoid (GC) treatment for classic congenital adrenal hyperplasia (CAH) and the potential advantages of introducing novel…
Children’s Therapeutics ScaleReady Partners with Industry Leaders to Support Seattle Announces Children’s Therapeutics ScaleReady, in partnership with Wilson Wolf Manufacturing and Bio-Techne Corporation, has announced that Seattle Children’s Therapeutics, a division of the prestigious Seattle Children’s Research Institute, has been…
Bio-Techne Prevails in Second Case Against Miltenyi Biotec for Reverse Engineering of Antibodies Corporation announced today that it has successfully won another legal claim against Miltenyi Biotec B.V. & Co. KG, which allegedly commercialized antibodies that were developed by reverse…
New Insights into Lecanemab’s Role in Slowing Alzheimer’s Disease Progression A groundbreaking study led by Professor Kenjiro Ono of the Institute of Medical, Pharmaceutical, and Health Sciences at Kanazawa University, in collaboration with Eisai Co., Ltd., has uncovered a crucial…
CoolMonth Returns with Exciting Offers on CoolSculpting® Elite by Allergan Aesthetics Allergan Aesthetics, an AbbVie company has announced the return of its third annual CoolMonth celebration, showcasing CoolSculpting® Elite. This event offers a prime opportunity for individuals exploring non-surgical body…
Cytokinetics, Incorporated has announced the granting of equity awards as material inducements to new employees under Nasdaq Listing Rule 5635(c)(4). These grants, made on December 31, 2024, include stock options, restricted stock units (RSUs), and performance stock units (PSUs) offered…
The “Precision Medicine Software Market: Focused Insights 2024-2029” explores the dynamics Genomics of a rapidly growing industry. Valued at USD 1.72 billion in 2023, the market is expected to grow to USD 3.50 billion by 2029, reflecting a robust compound…
BeiGene a global oncology Chemotherapy company that plans to rebrand itself as BeOne Medicines Ltd., has achieved a significant milestone with the U.S. Food and Drug Administration’s (FDA) approval of TEVIMBRA® (tislelizumab-jsgr). This approval pertains to its use in combination…
Argenx SE a global immunology company dedicated to improving the lives of people affected by severe autoimmune diseases, has announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved VYVDURA for the treatment of adults with chronic inflammatory…